Amlodipine, Valsartan, Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 51407-671

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan, Hydrochlorothiazide (NDC 51407-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-668-30 (Rev 09-22.jpg)

51407-668-30 (Rev 09-22.jpg)
The text describes a medication with the NDC code 51407-668-30 that contains Amlodipine, Valsartan, and Hydrochlorothiazide in the form of tablets. The tablets have a dosage of 5 mg/160 mg/12.5 mg and have instructions for the pharmacist to dispense patient information. Each tablet contains 6.9 mg of amlodipine besylate which is equivalent to 5 mg of amlodipine. The medication should be protected from moisture and kept out of the reach of children. The manufacturer is Strides Pharma, Inc. and the marketer is GSMS, Incorporated located in Camarillo, CA, USA.*
FDA Label Image

51407-669-30 (Rev 09-22.jpg)

51407-669-30 (Rev 09-22.jpg)
This is a description of a tablet medication that contains 6 mg of amiodipine besylate, equivalent to 5 mg of amlodipine and hydrochlorothiazide. The tablets come in a package of 30 and are required to be dispensed with patient information by a pharmacist. The dosage information is to be read in the accompanying Prescribing Information document. It is necessary to protect the tablets from moisture and store them between 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C to 30°C (59°F to 86°F). The medication is manufactured by Strides Pharma, Inc. and marketed by GSMS, Incorporated.*
FDA Label Image

51407-670-30 (Rev 09-22.jpg)

51407-670-30 (Rev 09-22.jpg)
Amlodipine/Valsartan/Hydrochlorothiazide tablets with NDC 51407-670-30 contains 10 mg/160 mg/12.5 mg strength for the treatment of high blood pressure. Each tablet contains 13.9 mg of Amlodipine Besylate equivalent to 10 mg of Amlodipine. The patient information can be obtained at https://gsms.us/. The medication must be kept away from moisture and children and stored at 20° - 25°C (68° - 77°F) with excursions permitted to 15° - 30°C (59° - 86°F). It is manufactured by Strides Pharma, Inc. and marketed by GSMS, Incorporated in Camarillo, CA 93012 USA. Please see accompanying prescribing information before use.*
FDA Label Image

51407-671-30 (Rev 09-22.jpg)

51407-671-30 (Rev 09-22.jpg)
This is a description of a medication called Amlodipine/Valsartan/Hydrochlorothiazide tablets that come in a pack of 30. Each tablet contains 13.9 mg of amlodipine besylate equivalent to 10 mg of amlodipine. The recommended dosage is in the accompanying Prescribing Information. It is important to protect from moisture and store at 20° - 25°C (68° - 77°F), excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature]. This medication should be kept out of the reach of children. Pharmacist is advised to dispense the Patient Information to each patient. For further information, please find patient information at gsms.us. The medication is manufactured by Strides Pharma, Inc. and marketed by GSMS, Incorporated, Camarillo, CA 93012 USA.*
FDA Label Image

51407-672-30 (Rev 09-22.jpg)

51407-672-30 (Rev 09-22.jpg)
Amlodipine/Valsartan/Hydrochlorothiazide Tablets, NDC 51407-672-30, is a prescription drug used to treat hypertension. Each tablet contains a combination of amlodipine, valsartan, and hydrochlorothiazide. The medication is to be dispensed along with the patient information available at https://gsms.us/. The dosage should be taken as per the prescribing information, and the medication should be protected from moisture and stored within the prescribed temperature range. The drug is manufactured by Strides Pharma, Inc. and marketed by GSMS, Incorporated.*
FDA Label Image

Amlodipine-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 40)

FDA Label Image

Valsartan-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 41)

FDA Label Image

Hctz-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 42)

FDA Label Image

Figure1 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 43)

Figure1 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 43)
The text only includes a caption for a graph labeled "Figure 1" with a title "Reduction in Mean Blood Pressure at Endpoint" and two lines with a scale for diastolic and systolic blood pressure. It does not provide any further information or data.*
FDA Label Image

Figure2 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 44)

Figure2 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 44)
This is a graph depicting mean sitting diastolic blood pressure by Treatment and Week. The graph shows blood pressure readings for different weeks and treatments, including AMUVAUHGTZ, VaUHCTZ, ATVl, and HCTZIAMI. The readings range from 80 to 110.*
FDA Label Image

Figure3 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 45)

Figure3 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 45)
The figure shows the mean sitting systolic blood pressure by treatment and week. The x-axis represents weeks and the y-axis displays the blood pressure in mmkg. The different treatments included in the comparison are: AMINAVHCTZ 10/32025 Mg = 3+ Va/KCTZ 32025 mg, Ami/al 10/620 mg, and HCTZAmI25/10 mg.*
FDA Label Image

Figure4 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 46)

Figure4 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 46)
The text is describing a figure labeled as "Figure 4". It shows the "Mean Ambulatory Diastolic Blood Pressure" at the endpoint by treatment and the hour. The graph has a vertical axis labeled from 60-100. The horizontal axis is labeled "Hours after dosing". There are two treatment groups represented: "Trament" and "AMVHOTZ 1032025 mg." The Trament group is represented by a solid line, and the AMVHOTZ group is represented by a dashed line. There are also two additional groups represented: "AniNVal 10320mg", and "HoTZAm 2510mg". The description does not provide further information on these 2 groups.*
FDA Label Image

Figure5 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 47)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.